5 research outputs found

    Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at One Year: an Open Label, Non-Randomized, Controlled Study

    No full text
    <p><b>Article full text</b></p><p><br></p><p>The full text of this article can be found here <a href="https://link.springer.com/article/10.1007/s13300-018-0373-9">https://link.springer.com/article/10.1007/s13300-018-0373-9</a></p><p><br></p><p><b>Provide enhanced content for this article</b></p><p><br></p><p>If you are an author of this publication and would like to provide additional enhanced content for your article then please contact [email protected].</p><p> </p><p>The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.</p><p><br></p><p>Other enhanced features include, but are not limited to:</p><p><br></p><p>• Slide decks</p><p>• Videos and animations</p><p>• Audio abstracts</p><p> </p><p>• Audio slides</p><ul> </ul> <p> </p

    Daily nutrient intakes at baseline (habitual diet) and during each dietary phase<sup>1</sup>.

    No full text
    <p><i><sup>1</sup>Values are mean ± SD.</i></p><p><i><sup>2</sup>Determined from 3-day diet records.</i></p><p>Daily nutrient intakes at baseline (habitual diet) and during each dietary phase<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0113605#nt105" target="_blank">1</a></sup>.</p

    Baseline subject characteristics<sup>1</sup>.

    No full text
    <p><i><sup>1</sup>Values are mean ± SD (range).</i></p><p><i><sup>2</sup>Determined by dual-energy X-ray absorptiometry.</i></p><p><i><sup>3</sup>HOMA  =  homeostatic model assessment  =  [fasting glucose (mmol/L) x insulin (mU/L)]/22.5.</i></p><p><i>*5 subjects were using anti-hypertensive medications.</i></p><p>Baseline subject characteristics<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0113605#nt101" target="_blank">1</a></sup>.</p

    Plasma fatty acid responses<sup>1</sup>.

    No full text
    <p><i><sup>1</sup>Values are mean ± SD from 16. SFA  =  total saturated fatty acids; MUFA  =  total monounsaturated fatty acids.</i></p><p><i><sup>2</sup>C1  =  lowest carbohydrate diet and C6  =  highest carbohydrate intake.</i></p><p><i><sup>3</sup>3wk run-in diet phase before entering feeding portion of study.</i></p><p><i><sup>4</sup>Dependent t-test (Baseline vs C1).</i></p><p>Plasma fatty acid responses<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0113605#nt107" target="_blank">1</a></sup>.</p
    corecore